BRIEF published on 06/17/2025 at 07:05, 11 months 11 days ago Innate Pharma participera à des conférences d'investisseurs clés Biotechnologie Immunothérapie Soins De Santé Conférences D'investisseurs Innate Pharma
PRESS RELEASE published on 06/17/2025 at 07:00, 11 months 11 days ago Inside Information / Other news releases Innate Pharma to participate in H.C. Wainwright and Wolfe Research healthcare conferences showcasing their innovative immunotherapy approaches. Global biotech company expanding portfolio Biotechnology Immunotherapy Clinical-stage Innate Pharma Healthcare Conferences
BRIEF published on 06/13/2025 at 07:05, 11 months 15 days ago Innate Pharma's IPH6501 Shows Potential in Lymphoma Treatment Innate Pharma Preclinical Results IPH6501 Lymphoma R-CHOP
BRIEF published on 06/13/2025 at 07:05, 11 months 15 days ago L'IPH6501 d'Innate Pharma montre un potentiel dans le traitement du lymphome Innate Pharma Résultats Précliniques IPH6501 R-CHOP Lymphome
PRESS RELEASE published on 06/13/2025 at 07:00, 11 months 15 days ago Inside Information / Other news releases Innate Pharma highlights preclinical antitumor activity of IPH6501 in DLBCL and FL at the 2025 EHA Congress, presenting potent efficacy in in vitro and in vivo models with R-CHOP combination Preclinical Data EHA Congress Innate Pharma Antitumor Activity IPH6501
BRIEF published on 05/13/2025 at 07:05, 1 year ago Innate Pharma publie ses résultats du premier trimestre 2025 Résultats Financiers Essais Cliniques Innate Pharma Investissement Sanofi Lacutamab FDA
BRIEF published on 05/13/2025 at 07:05, 1 year ago Innate Pharma Reports First Quarter 2025 Results Financial Results Clinical Trials Innate Pharma Sanofi Investment Lacutamab FDA
PRESS RELEASE published on 05/13/2025 at 07:00, 1 year ago Informations privilégiées / Communiqué sur comptes, résultats Innate Pharma annonce ses résultats financiers du premier trimestre 2025 et les avancées de son portefeuille, incluant des investissements et des études cliniques. Une conférence téléphonique est prévue à 14h00 CEST Résultats Financiers Conférence Téléphonique Portefeuille Études Cliniques Innate Pharma
PRESS RELEASE published on 05/13/2025 at 07:00, 1 year ago Inside Information / News release on accounts, results Innate Pharma reports Q1 2025 business update with €15 million investment by Sanofi, FDA Breakthrough Therapy Designation for lacutamab, and cash position of €72.5 million FDA Financial Results Sanofi Innate Pharma Q1 2025
BRIEF published on 05/02/2025 at 15:27, 1 year ago Sanofi augmente sa participation dans Innate Pharma Capital Actions Franchissement De Seuils Sanofi Innate Pharma
Published on 05/28/2026 at 13:30, 8 minutes ago ROK Resources Files Financial Results and Management Discussion & Analysis for First Quarter of 2026
Published on 05/28/2026 at 13:00, 38 minutes ago Galway Metals' District-Scale Geophysics Defines High-Priority Target Corridor Between Clarence Stream's Two Largest Gold Deposits
Published on 05/28/2026 at 13:00, 38 minutes ago Aztec Minerals Increases Tombstone Drilling Program by 3,500 Meters
Published on 05/28/2026 at 13:00, 38 minutes ago INEO Tech Corp. Reports Record Quarterly Revenue For Fiscal Q3 FY2026
Published on 05/28/2026 at 12:30, 1 hour 8 minutes ago White Gold Corp. Commences 2026 Exploration Program Designed to Further Increase Known Gold Resources and Make New Discoveries on its District Scale Land Package in Yukon, Canada
Published on 05/28/2026 at 13:15, 23 minutes ago Global Filmmakers Are Leveraging Kling AI to Push the Boundaries of Storytelling, Cannes Panel Presents
Published on 05/28/2026 at 13:15, 23 minutes ago Des cinéastes du monde entier utilisent Kling AI pour repousser les limites de la narration, selon un panel à Cannes
Published on 05/28/2026 at 13:12, 25 minutes ago Share Buyback for the Employee Participation Program
Published on 05/28/2026 at 12:56, 41 minutes ago 20 years of KION – connecting the heritage with the future at the Annual General Meeting 2026
Published on 05/28/2026 at 12:30, 1 hour 8 minutes ago Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Published on 05/28/2026 at 10:30, 3 hours 8 minutes ago Recticel Group opgenomen in Financial Times-lijst van Europese Klimaatleiders
Published on 05/28/2026 at 10:30, 3 hours 8 minutes ago Recticel Group included in Top 100 Financial Times list of Europe’s Climate Leaders
Published on 05/28/2026 at 08:45, 4 hours 53 minutes ago Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski
Published on 05/28/2026 at 08:45, 4 hours 53 minutes ago Nomination de Mikael Frenkian en qualité de Directeur Général de Baikowski
Published on 05/28/2026 at 08:30, 5 hours 8 minutes ago Cegedim Business Services renforce sa conformité et sa sécurité avec deux distinctions majeures
